Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Argatroban bulk supplier for pharma manufacturers

Argatroban 100 mg/ mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg/ mL

Reference Brands: Generic formulations marketed under different names

Category: Critical Care

Argatroban is a Critical Care product available as Injection in strengths 100 mg/ mL. It corresponds to the reference brand Generic formulations marketed under different names. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Argatroban is an intravenous anticoagulant medication used for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT), a rare but potentially life-threatening immune-mediated complication associated with heparin therapy. It belongs to the class of direct thrombin inhibitors and provides effective anticoagulation without cross-reactivity with heparin antibodies.

Argatroban works by directly and reversibly inhibiting thrombin, thereby preventing fibrin formation, platelet aggregation, and clot development. It is commonly used in hospitalized and critical care settings, including during percutaneous coronary interventions in patients with HIT who require ongoing anticoagulation. Due to its rapid onset of action and short half-life, argatroban allows precise dose adjustments and close control of anticoagulant effects.

The drug is administered by continuous intravenous infusion and requires careful monitoring using activated partial thromboplastin time (aPTT). Argatroban is primarily metabolized in the liver, making it suitable for patients with renal impairment, though dose adjustments are necessary in hepatic dysfunction. Awareness of potential drug interactions, bleeding risks, and patient-specific factors is essential for safe and effective therapy. When used appropriately, argatroban remains a valuable and reliable anticoagulant option in the management of HIT.

Argatroban — third party manufacturing & bulk supply

Argatroban 100 mg/ mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Argatroban listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Argatroban →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions


Argatroban is used for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia. It is also used as an anticoagulant in patients with HIT undergoing percutaneous coronary intervention.


Argatroban is a synthetic small-molecule direct thrombin inhibitor derived through chemical synthesis and designed to selectively inhibit thrombin activity.


The trade name of argatroban is Argatroban Injection.


Argatroban was originally developed by Mitsubishi Tanabe Pharma and is currently manufactured and marketed by multiple pharmaceutical companies worldwide as approved generic injectable formulations.


The generic name of this medicine is argatroban.


The brand name is Argatroban Injection.


Argatroban injection is manufactured by various FDA-, EMA-, and MHRA-approved pharmaceutical manufacturers, with production sites varying by supplier and region.

Related Products

Ringer's Lactate

Strength:
100 mL, 250 mL, 500 mL, 1000ml

Form: Infusion

Reference Brands: Generic formulations marketed under different names

View Details
Rolapitant Hydrochlorid

Strength:
90 mg

Form: Tablets

Reference Brands: Varubi(USA/LATAM), Varuby(EU)

View Details
Conivaptan Hydrochloride

Strength:
20 mg/100 mL

Form: Infusion

Reference Brands: Vaprisol (USA)

View Details
Fitusiran

Strength:
50 mg/0.5 ml, 20 mg/0.2ml

Form: injection (prefilled syringe)

Reference Brands: Generic formulations marketed under different names

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.